Menstrual Disorders Flashcards
1
Q
Dysmenorrhea
A
-
Definition:
- painful menstruation that affects normal activities
-
Types:
- Primary: due to increased prostaglandin (PGF2a) production by endometrium → painful uterine wall contractions; teens/early 20s
- Secondary: due to pelvis or uterus pathology (i.e. endometriosis, PID, adenomyosis, leiomyomas (fibroids)); common with increased age
-
S/sxs:
- recurrent cramping at the midline of the lower abdomen at the onset of menses that gradually diminishes over 12-72 hours (primary) or throughout menses (secondary)
-
PE:
- **Usually normal
- Normal pelvic exam, no physical findings that support symptoms → primary dysmenorrhea
- Asymmetry or irregular uterine enlargement → fibroid (leiomyomas)
- Tender, asymmetrical enlarged “boggy” uterus → adenomyosis
- Cervical Motion Tenderness, adnexal pain, inguinal lymphadenopathy, fever, purulent cervical drainage → PID
- **Usually normal
-
Dx:
- Clinical diagnosis
- Labs/imaging may be needed if pelvic disease is suspected
- Note: childbearing has no effect on primary or secondary dysmenorrhea
-
Tx:
- Supportive: hot compresses
-
Primary: NSAIDs
- -Estrogen-Progestin OCPs
- -Laparoscopy: if unresponsive to 3 cycles of initial therapy to r/o secondary causes
-
Secondary: tx the underlying condition
- (ex. Combined OCPs for endometriosis)
2
Q
Premenstrual Syndrome
A
- Definition: cluster of physical, behavioral, and mood changes with cyclical occurrence during the of the luteal phase menstrual cycle
-
Epidemiology:
- very common (premenstrual symptoms in 75-85% of women, 5-10% have PMS)
-
S/sxs:
-
*symptoms occurring 1-2 weeks before menses & relieved with onset of menses
- Physical: abd bloating, fatigue, breast tenderness/swelling, weight gain, headache, changes in bowel habits
- Emotion: irritability, tension, depression, anxiety, libido changes
- Behavioral: food cravings, poor concentration, noise sensitivity
-
*symptoms occurring 1-2 weeks before menses & relieved with onset of menses
-
PE:
- have pts record a diary of symptoms for multiple cycles
-
Dx:
- subjective Dx
- PMDD Criteria
-
Tx:
- Lifestyle mods: stress reduction & exercise, reduction of caffeine/EtOH/salt
- PMS: NSAIDs (for dysmenorrhea), OCPs (1st line for some)
- PMDD: SSRIs (fluoxetine, sertraline, citalopram) are gold standard
3
Q
Premenstrual Dysphoric Dysphoric Disorder Criteria (DSM-V)
A
- *5 of the following with at least 1 from the first 4
- Depressed mood or hopelessness
- anxiety or Tension
- Lability (strong emotions)
- Increased or Persistent Anger, irritability of conflicts
- decreased interest, difficulty concentrating, lethargy, change in appetite, hyper/insomnia, overwhelmed
4
Q
Amenorrhea (Primary)
A
-
Definition:
- failure of menarche onset by age 16 (in the presence of secondary sex characteristics) or by age 13yo (in the absence of secondary sex characteristics)
-
S/sxs:
- No menstrual bleeding
-
PE:
- consider eval by age 15 or no menstruation within 3 years of thelarche (onset of breast development)
-
Dx:
- hCG to r/o pregnancy if sexually active
- FSH, TSH, Prolactin
-
Tx:
- tx the underlying problem
5
Q
Amenorrhea (Secondary)
A
-
Definition:
- absence of menses for >3 months in a pt with a previously normal menstruation cycle or for the duration of 3 typical menstrual cycles for the patient with oligomenorrhea
-
Etiology:
- Pregnancy = MCC (95%)
- Hypothalamus dysfx: function (poor nutrition/stress alters feedback to the brain that regulates the menstrual cycle), drug induced, psychogenic (anorexia), head injury
- Pituitary Dysfnx: prolactinoma or pituitary infarct (Sheehan syndrome)
- Ovarian Dysfnx: decreased estrogen & increased LH/FSH; PCOS, premature ovarian failure, Turner Syndrome, savage syndrome
- Outflow tract dysfxn: Asherman’s syndrome (acquisition of scar tissue in uterus that causes blockage often d/t surgery or cancer tx) , imperforate hymen, no uterus/vagina
-
S/sxs:
- no menstrual bleeding
- Female Athlete Triad:
- -hypothalamic amenorrhea, eating disorder, osteoporosis
- *Note: you need to be ~115 lbs to maintain cycle
-
Dx:
- hCG = 1st test to r/o pregnancy
- *if hCG negative then order:
- → serum prolactin, FSH, LH, TSH, estrogen
- → testosterone if evidence of hirsutism or hyperandrogenism
6
Q
Hypothalamic Dysfunction in Amenorrhea (secondary)
A
- Disruption of GnRH pulsatile release & feedback of sex steroids from ovaries → pituitary not stimulated to secrete FSH/LH
- → absence of normal follicular development (despite some estrogen production)
- → no ovulation or support of corpus luteum
- → no stimulation of endometrium
- → no menstruation
- **age matters: axis is immature the first decade after menses, mature from 20-40, & declines after 40
7
Q
Abnormal Uterine Bleeding
A
-
Definition:
- unexplained abnormal bleeding in nonpregnant woman in regard to quantity, frequency, or duration. Usually occurs just after menarche or in perimenopausal period
-
Etiology:
- Pregnancy
- Uterine-Structural (PALM): polyp, adenomyosis, leiomyoma, malignancy (any postmenopausal bleed is cancer until proven otherwise)
- Uterine-nonstructural (COEIN): coagulopathy (von Willebrand), ovulatory dysfunction (PCOS, stress, adrenal hyperplasia, thyroid probs), endometrial, iatrogenic (OCPs, warfarin), not yet known/classified
-
S/sxs:
- abnormal bleeding
-
Types:
- Anovulatory = most common: unpredictable bleeding with variable flow/duration d/t chronic estrogen production unopposed by progesterone → endometrium proliferation that eventually outgrows its blood supply & is necrotic
- Ovulatory: cyclic but heavy/prolonged bleeding d/t uterine structural conditions, normal gonadotropin/sex steroid levels
-
PE:
- Skin: hirsutism, acne, striae, acanthosis, nigricans, easy bruising
- Breast: galactorrhea
- Thyroid
- Abdomen: uterine fibroids, enlarged uterus, splenomegaly
- Pelvic: atrophic changes, cervicitis, cervical carcinoma
-
Dx:
- hCG to r/o pregnancy
-
3 question algorithm?
- Is she pregnant?
- Is the bleeding from the uterus or elsewhere?
- If bleeding is from the uterus, is she ovulating or having anovulatory bleeding?
- CBC: hgb & hct
- TSH, PAP screen, Prolactin, FSH/LH, STI screen, serum androgens & testosterone: if hirsutism
- Endometrial biopsy to r/o endometrial biopsy to r/o endometrial carcinoma in all women > 35 yo with obesity, HTN, or DM
- *if ovulatory: do US to check for polyps or fibroids
-
Tx:
- Tx the underlying etiology (i.e. surgery for structural lesions)
- Progestin based treatment: medroxyprogesterone acetate x 10 days (1st line), OCPs or IUD as alternative
- Acute heavy menstrual bleeding: high-dose estrogen & progestin therapy OR OCP 3 pills/day x1 week + Tranexamic acid → ongoing therapy with IUD, OCPs, progestins, tranexamic acid, & NSAIDs
8
Q
When to Evaluate for Endometrial Cancer
A
- Any post-menopausal bleeding
- 45 yo to menopause: any AUB that is frequen, heavy or prolonged
- < 45 yo: any AUB with chronic ovulatory dysfunction, exposure to estrogen unopposed by progesterone, failed medical management bleeding, Lynch or Cowden syndrome
- Premenopausal: with amenorrhea/anovulatory > 6 months
9
Q
Menopause: definition, Premature menopause, S/sxs, PE, & Dx
A
-
Definition:
- cessation of menses for more than 12 consecutive months due to natural loss of ovarian follicular function (follicles become less responsive to FSH & LH) → decreased estrogen & progesterone production
- Average age: 52 yo
-
Premature Menopause (<40yo):
- can occur with medical intervention (chemotherapy, bilateral oophorectomy, radiation, medication, impaired ovarian function); also called induced menopause
-
S/sx:
- variable bleeding pattern
- Vasomotor instability: hot flashes (75%), night sweats
- vaginal dryness → dyspareunia
- Sleep disturbance
- Mood changes: depression, anxiety, moodiness (worse if prior hx)
- Cognitive concerns: memory concentration (d/t normal aging but also menopause)
-
PE:
- dry & thin skin
- vaginal atrophy
- decreased breast size
- decreased bone density → increased risk of osteoporosis
-
Dx:
- increased FSH & LH
- Decreased estrogen
- **do not need these to confirm dx
10
Q
Tx of Menopause
A
Hormone Replacement Therapy = “individualized therapy”
- *ideal candidate = recently menopausal (within 10 years), highly symptomatic, no contraindications, age < 60yo
-
Hormone replacement therapy: estrogen & progestin (if uterus present), estrogen (if no uterus), or bioidentical hormone therapy
- may increase risk of breast cancer & clots → need to screen for ASCVD: ≥7.5 = contraindication; risk of breast cancer > 5% = also contraindication
- Hormones not used for disease prevention, just to tx annoying sxs
-
Contraindications:
- high triglycerides
- undiagnosed vaginal bleeding
- endometrial cancer
- hx of breast Ca or estrogen sensitive cancers
- CVD hx
- DVT or PE hx
-
Hormone replacement therapy: estrogen & progestin (if uterus present), estrogen (if no uterus), or bioidentical hormone therapy
-
Other tx options:
- lifestyle: dress in layers, reduce EtOH & caffeine consumption, cool air temp, sip cool drinks, maintain healthy BMI, exercise
- low dose OCPs
- Antidepressants: SSRI (Fluoxetine), SNRI (Venlafaxine)
- Anticonvulsant: gabapentin
- Neuropathic Pain: Pregabalin
- Bazedoxifene: selective estrogen receptor modulator
- Osteoporosis: calcium & vitamin D supplements
11
Q
Postmenopausal Concerns
A
- Osteoporosis, weight management, cardiovascular disease, sexual function, dermatologic (skin & hair), cancer risks (d/t age)
- **Body adjusts to hormone changes after a couple years (hot flashes resolve after 3-5yrs)
12
Q
Perimenopause
A
-
Definition:
- “menopause transition”. Starts when menstrual cycle length starts to vary by > 7days & lasts up until final menstrual period; usually lasts 3-5 years.
-
S/sxs:
- variable bleeding patterns: light & sporadic vs heavier menses
- *More symptomatic than during menopause
-
Dx:
- increased FSH (fluctuates)